The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter sales ...

The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...

UnitedHealth's high medical costs and lower-than-expected revenue in the fourth quarter underscored persistent challenges at ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

The U.S. Food and Drug Administration has expanded the approval for Johnson & Johnson's nasal spray Spravato to allow its ...

By Sriparna Roy and Bhanvi Satija (Reuters) -UnitedHealth CEO Andrew Witty said on Thursday that healthcare in the U.S. needs ...

The U.S. government will consider opportunities to "bring greater transparency" for the Medicare drug price negotiation ...